Biologics for pediatric atopic dermatitis: A protocol of a systematic review and meta-analysis
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0271712 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, 2023. Verfasst von Rui Cao und 2 weiteren Autor:innen. Beteiligte Einrichtung: North China University of Science and Technology, Hebei, Tangshan, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Biological Products. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Atopic dermatitis is a chronic pruritic inflammatory skin disease commonly occurring in children. The objective of this study is to evaluate the treatment of pediatric atopic dermatitis with biologics, as they have displayed immense promising results in several recent clinical trials on atopic dermatitis (AD).
Methods
We will conduct an extensive search for RCTs in several databases, including Embase, Cochrane Library, Web of Science, and PubMed, from the inception of the study till 15th May 2022. The primary outcomes will be the proportion of patients with EASI 75/90/100 after 12–16 weeks of treatment. The secondary outcomes will include the Numerical Rating Scale (NRS), Investigator Global Assessment (IGA)0–1, body surface area (BSA), Dermatology Life Quality Index (DLQI) scores, and incidence of adverse reactions. All studies will be screened by two independent researchers. They will assess the risk of bias in the included studies according to the RCTs bias risk evaluation tool in Cochrane System Review Manual 5.1.0. Meta-analysis will be performed using RevMan V.5.3.0 software.
Results
The research results will provide a reference for the clinical application of biological agents in pediatric atopic dermatitis.
Conclusion
We aim to evaluate the efficacy and safety of biologics in pediatric atopic dermatitis cases and provide evidence-based data for easy clinical application. PROSPERO registration number CRD42022319052 ( https://www.crd.york.ac.uk/PROSPERO/#joinuppage ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- North China University of Science and Technology, Hebei, Tangshan, China.
- Tangshan Gongren Hospital, Hebei, Tangshan, China.
ORCID-Profile: Rui Cao
Zitieren
APA
Cao, R., Lu, J., & Chen, Z. (2023). Biologics for pediatric atopic dermatitis: A protocol of a systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0271712
Vancouver
Cao R, Lu J, Chen Z. Biologics for pediatric atopic dermatitis: A protocol of a systematic review and meta-analysis. PLOS ONE. 2023. doi:10.1371/journal.pone.0271712
BibTeX
@article{Cao2023,
author = {Cao, Rui and Lu, Jiaxing and Chen, Zhao},
title = {Biologics for pediatric atopic dermatitis: A protocol of a systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0271712}
}
EUVIMED